Skip to main content

Table 3 Summary of blood cell types in the different groups at the acute phase (AP) and receding pandemic (CP) phases

From: Cross-sectional study of the relationship of peripheral blood cell profiles with severity of infection by adenovirus type 55

  Healthy controls (n = 30) Phase Silent infection (n = 30) Minor infection (n = 27) Severe infection (n = 34) P-value
WBC, 10 9 /L 5.18 ± 1.21 AP 6.03 ± 1.13 5.49 ± 1.58 6.21 ± 2.96 0.1333
CP 6.17 ± 1.32b ND 5.78 ± 1.40 0.0164a
Neutrophil, fraction 0.57 ± 0.08 AP 0.51 ± 0.09 0.51 ± 0.14 0.61 ± 0.15c,d 0.0020a
CP 0.52 ± 0.08 ND 0.50 ± 0.09b,e 0.0026a
Lymphocyte, fraction 0.34 ± 0.07 AP 0.38 ± 0.08 0.34 ± 0.15 0.27 ± 0.13c 0.0009a
CP 0.36 ± 0.08 ND 0.39 ± 0.08e 0.0609
Monocyte, fraction 0.07 ± 0.02 AP 0.09 ± 0.02 0.13 ± 0.03b,c 0.11 ± 0.04b,c <0.0001a
CP 0.09 ± 0.02 ND 0.09 ± 0.02e 0.0001a
PLT, 10 9 /L 207.13 ± 36.88 AP 260.40 ± 54.22b 213.81 ± 47.54c 181.47 ± 48.33c <0.0001a
   CP 224.37 ± 39.78e ND 253.00 ± 51.70b,c,e 0.0004a
  1. AP, acute phase; CP, convalescent phase; ND, not determined; WBC, white blood cells; PLT, platelet.
  2. asignificant differences in the four groups by one-way ANOVA.
  3. bsignificant difference from the healthy control group.
  4. csignificant difference from the silent infection group.
  5. dsignificant difference from the minor infection group.
  6. esignificant difference from the AP phase within a group.